| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 54.97B | 59.12B | 54.29B | 51.23B | 50.16B | 46.48B |
| Gross Profit | 12.81B | 14.72B | 12.38B | 11.99B | 12.31B | 11.58B |
| EBITDA | 5.70B | 4.71B | 5.82B | 5.37B | 5.83B | 4.43B |
| Net Income | 3.81B | 4.80B | 3.53B | 3.17B | 3.46B | 2.79B |
Balance Sheet | ||||||
| Total Assets | 60.41B | 70.28B | 66.66B | 65.16B | 58.78B | 54.60B |
| Cash, Cash Equivalents and Short-Term Investments | 9.43B | 11.17B | 10.27B | 10.83B | 11.30B | 10.74B |
| Total Debt | 833.00M | 876.00M | 957.00M | 1.18B | 1.25B | 1.22B |
| Total Liabilities | 13.61B | 17.70B | 19.87B | 21.00B | 20.38B | 19.37B |
| Stockholders Equity | 46.80B | 52.58B | 46.79B | 44.16B | 38.40B | 35.23B |
Cash Flow | ||||||
| Free Cash Flow | 919.50M | 816.00M | 238.00M | 506.00M | 1.08B | 2.53B |
| Operating Cash Flow | 1.31B | 2.82B | 1.86B | 1.74B | 1.88B | 3.12B |
| Investing Cash Flow | -576.00M | -2.37B | 738.00M | -1.09B | -683.00M | 2.59B |
| Financing Cash Flow | -370.50M | -1.58B | -1.35B | -1.18B | -828.00M | -5.93B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | ¥45.41B | 9.33 | ― | 3.21% | 8.90% | 35.83% | |
75 Outperform | ¥53.44B | 9.50 | ― | 1.94% | -2.66% | -9.83% | |
72 Outperform | ¥70.69B | 11.56 | ― | 2.31% | 3.34% | -8.24% | |
69 Neutral | ¥26.81B | 12.06 | ― | 2.89% | 7.91% | 2.84% | |
67 Neutral | ¥33.17B | 6.33 | ― | 2.29% | 12.40% | 7.55% | |
66 Neutral | ¥8.68B | 7.40 | ― | 2.45% | 14.74% | -73.19% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% |